Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | PDE4A | P27815 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13062507 | 1.00 | SLC22A6 (0.50) | SLC22A6SMN1; SMN2PDE4ALMNAGABRR1 | |
| SCHEMBL19331126 | 1.00 | SLC22A6 (0.50) | SLC22A6SMN1; SMN2PDE4ALMNAGABRR1 | |
| SCHEMBL6629736 | 1.00 | SLC22A6 (0.50) | SLC22A6SMN1; SMN2PDE4ALMNAGABRR1 | |
| Alcohol SCHEMBL6272385 | 0.92 | SLC22A6 (0.43) | SLC22A6SMN1; SMN2PDE4ALMNAGABRR1 | |
| SCHEMBL5437765 | 0.87 | SLC22A6 (0.62) | SLC22A6SMN1; SMN2LMNAGABRR1TDP1 | |
| SCHEMBL3902208 | 0.87 | SLC22A6 (0.62) | SLC22A6SMN1; SMN2LMNAGABRR1TDP1 | |
| SCHEMBL4721742 | 0.87 | SLC22A6 (0.62) | SLC22A6SMN1; SMN2LMNAGABRR1TDP1 | |
| Methacrylic Acid SCHEMBL28667288 | 0.84 | TGFBR1 (0.37) | SLC22A6SMN1; SMN2PDE4ALMNAGABRR1 | |
| SCHEMBL2933537 | 0.83 | PDE4A (0.52) | SLC22A6SMN1; SMN2PDE4ALMNAGABRR1 | |
| SCHEMBL18105811 | 0.83 | PDE4A (0.52) | SLC22A6SMN1; SMN2PDE4ALMNAGABRR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 149 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7858775-B2 | Production of 2′-deoxynucleosides and 2′-deoxynucleoside precursors from 2-dehydro-3-deoxy-D-gluconate | RHODIA CHIMIE (FR) | 2010-12-28 | — | — | US | claimed |
| US-20050075258-A1 | Dishwasher detergent with improved protection against glass corrosion | HENKEL AG & CO. KGAA (DE) | 2005-04-07 | — | — | US | claimed |
| EP-1417291-A2 | DISHWASHER DETERGENT WITH IMPROVED PROTECTION AGAINST GLASS CORROSION N | Henkel Kommanditgesellschaft auf Aktien (DE) | 2004-05-12 | — | — | EP | claimed |
| WO-2003016444-A2 | DISHWASHER DETERGENT WITH IMPROVED PROTECTION AGAINST GLASS CORROSION | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2003-02-27 | — | — | WO | claimed |
| WO-2002097025-A1 | METHOD AND ADDITIVES REQUIRED FOR INCREASING THE STABILITY OF TABLETS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2002-12-05 | — | — | WO | claimed |
| WO-2025228828-A1 | CARBOXAMIDE COMPOUNDS FOR THE TREATMENT AND PREVENTION OF VIRAL DISEASES | MERCK PATENT GMBH (DE) | 2025-11-06 | — | — | WO | disclosed |
| US-20250258146-A1 | QUANTITATIVE DETECTION METHOD OF MULTIPLE METABOLITES IN BIOLOGICAL SAMPLE AND METABOLIC CHIP | HUMAN METABOLOMICS INSTITUTE INC. (CN) | 2025-08-14 | — | — | US | disclosed |
| EP-4594520-A2 | COMPOSITIONS CONTAINING OLIGONUCLEOTIDES WITH THERANOSTIC APPLICATIONS | Sixfold Bioscience Ltd. (GB) | 2025-08-06 | — | — | EP | disclosed |
| US-20240376180-A1 | HUMAN RECOMBINANT MONOCLONAL ANTIBODY AGAINST SARS-COV-2 SPIKE GLYCOPROTEIN | DEUTSCHES ZENTRUM FUR NEURODEGENERATIVE ERKRANKUNGEN E.V. (DZNE) (DE) | 2024-11-14 | — | — | US | disclosed |
| US-20240269198-A1 | COMPOSITIONS AND METHODS FOR IMPROVING SKIN HEALTH AND FOR THE TREATMENT AND PREVENTION OF DISEASES, DISORDERS AND CONDITIONS ASSOCIATED WITH FUNGI AND OTHER PATHOGENIC MICROBES | DERMBIONT, INC. | 2024-08-15 | — | — | US | disclosed |
| WO-2024069235-A2 | COMPOSITIONS CONTAINING OLIGONUCLEOTIDES WITH THERANOSTIC APPLICATIONS | Sixfold Bioscience Ltd. (GB) | 2024-04-04 | — | — | WO | disclosed |
| EP-4157867-A1 | HUMAN RECOMBINANT MONOCLONAL ANTIBODY AGAINST SARS-COV-2 SPIKE GLYCOPROTEIN | Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE) (DE) | 2023-04-05 | — | — | EP | disclosed |
| US-5808038-A | ANTICARCER AGENT | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1998-09-15 | — | — | US | disclosed |
| US-5750735-A | CHEMICAL INTERMEDIATES FOR ANTIBIOTICS | AMERICAN CYANAMID COMPANY (US) | 1998-05-12 | — | — | US | disclosed |
| US-5744465-A | Method of inhibiting a β-lactamase enzyme by administering novel 2-thiosubstituted carbapenems | AMERICAN CYANAMID COMPANY (US) | 1998-04-28 | — | — | US | disclosed |
| US-5623081-A | USING BENZYLOXYACETALDEHYDE DIMETHYL ETHER, HALOGENATED 1-PHENYLMETHOXY-4-PENTEN-2-OL; CYCLIZATION | LIN YANG-I (US) | 1997-04-22 | — | — | US | disclosed |
| US-5602118-A | A 2-((2-SUBSTITUTED ALKYL)FUR-3-YL)-THIO-),3-CARBOXY-2-CARBOPENEM DERIVATIVES; EFFECTIVE AGAINST BETA-LACTAM ANTIBIOTIC-RESISTANT BACTERIA | AMERICAN CYANAMID COMPANY (US) | 1997-02-11 | — | — | US | disclosed |
| EP-0617036-A2 | Novel 2-thiosubstituted carbapenems | AMERICAN CYANAMID COMPANY (US) | 1994-09-28 | — | — | EP | disclosed |
| US-4448912-A | QUATERNIZATION WITH PRIMARY AND/OR SECONDARY AMINE AND ACID | HOECHST AKTIENGESELLSCHAFT (DE) | 1984-05-15 | — | — | US | disclosed |
| EP-0058942-A1 | Thermosettable binders based on an aqueous dispersion of a solid epoxy resin, method for their preparation and their application | HOECHST AKTIENGESELLSCHAFT (DE) | 1982-09-01 | — | — | EP | disclosed |